CLINICAL_TRIALS
trial_result
· 2015-10-12
Clinical Trial Update: Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast Cancer [Phase 2]
Summary
Phase 2 trial evaluating the efficacy and safety of combining BMS-690514 with letrozole for metastatic breast cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED